Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation

Digestive Diseases and Sciences

Volumn 55, Issue 3, 2010, Pages 808-814

  Yoneda, Masato ^a   Nozaki, Yuichi ^a   Endo, Hiroki ^a   Mawatari, Hironori ^a   Iida, Hiroshi ^a   Fujita, Koji ^a   Yoneda, Kyoko ^a   Takahashi, Hirokazu ^a   Kirikoshi, Hiroyuki ^a   Inamori, Masahiko ^a   Kobayashi, Noritoshi ^a   Kubota, Kensuke ^a   Saito, Satoru ^a   Maeyama, Shiro ^b   Hotta, Kikuko ^c   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Kitakashiwa Rehabilitation Hospital   (Japan)

^c RIKEN   (Japan)

Author keywords

HFE; Hyperferritinemia; Insulin resistance; NAFLD; NASH

Indexed keywords

FERRITIN; HFE PROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FATTY LIVER; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPERFERRITINEMIA; INSULIN RESISTANCE; JAPANESE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ASIAN; BLOOD; GENETICS; MIDDLE AGED; MUTATION; RECEIVER OPERATING CHARACTERISTIC;

ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; FATTY LIVER; FEMALE; FERRITINS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; MUTATION; ROC CURVE;

EID: 77949330202     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0771-y     Document Type: Article

References (40)

1. P Angulo 2002 Nonalcoholic fatty liver disease N Engl J Med 18 1221 1231 10.1056/NEJMra011775 (Pubitemid 34984585)
2. GC Farrell 2003 Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 18 124 138 10.1046/j.1440-1746.2003.02989.x 12542595 (Pubitemid 36349857)
3. AM Diehl Z Goodman KG Ishak 1998 Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury Gastroenterology 95 1056 1062
4. J Ludwig TR Viggiano DB McGill BJ Oh 1980 Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 434 438 1:STN:280:DyaL3c3gvVeqtQ%3D%3D 7382552 (Pubitemid 10057164)
5. M Yoneda H Mawatari K Fujita, et al. 2007 Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage J Gastroenterol 42 375 381 10.1007/s00535-007-2014-3 1:CAS:528:DC%2BD2sXlslOgs7g%3D 17530362 (Pubitemid 47097254)
6. M Yoneda H Mawatari K Fujita, et al. 2007 High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH J Gastroenterol 42 573 582 10.1007/s00535-007-2060-x 1:CAS:528:DC%2BD2sXotFygsLg%3D 17653654 (Pubitemid 47190075)
7. M Yoneda T Uchiyama S Kato, et al. 2008 Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH) BMC Gastroenterol 8 53 10.1186/1471-230X-8-53 19014569
8. M Yoneda M Yoneda K Fujita, et al. 2007 Transient elastography in patients with nonalcoholic fatty liver disease (NAFLD) Gut 56 1330 1331 10.1136/gut.2007.126417 17470477 (Pubitemid 47300449)
9. M Yoneda M Yoneda H Mawatari, et al. 2008 Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD) Dig Liver Dis 40 371 378 10.1016/j.dld.2007.10.019 1:CAS:528:DC%2BD1cXns1yhsLc%3D 18083083
10. S Saadeh ZM Younossi EM Remer, et al. 2002 The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 745 750 10.1053/gast.2002.35354 12198701 (Pubitemid 34977081)
11. CP Day OF James 1998 Steatohepatitis: a tale of two "hit"? Gastroenterology 114 842 845 10.1016/S0016-5085(98)70599-2 1:STN:280: DyaK1c3htFartQ%3D%3D 9547102 (Pubitemid 28160420)
12. DK George S Goldwurm GA MacDonald, et al. 1998 Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 311 318 10.1016/S0016-5085(98)70482-2 1:STN:280:DyaK1c7hsVagtA%3D%3D 9453491 (Pubitemid 28093538)
13. OF James CP Day 1998 Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance J Hepatol 29 495 501 10.1016/S0168-8278(98) 80073-1 1:CAS:528:DyaK1cXmvVWns7Y%3D 9765002 (Pubitemid 28396672)
14. HL Bonkovsky Q Jawaid K Tortorelli, et al. 1999 Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis J Hepatol 31 421 429 10.1016/S0168-8278(99)80032-4 1:CAS:528:DyaK1MXmtFKgu7c%3D 10488699 (Pubitemid 29408723)
15. MH Mendler B Turlin R Moirand, et al. 1999 Insulin resistance-associated hepatic iron overload Gastroenterology 117 1155 1163 10.1016/S0016-5085(99) 70401-4 1:STN:280:DC%2BD3c%2FgsF2itQ%3D%3D 10535879 (Pubitemid 29512675)
16. DR Matthews JP Hosker AS Rudenski, et al. 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D 3899825 (Pubitemid 15018832)
17. T Yoshizumi T Nakamura M Yamane, et al. 1999 Abdominal fat: standardized technique for measurement at CT Radiology 211 283 286 1:STN:280: DyaK1M3gsFCrsQ%3D%3D 10189485 (Pubitemid 29161765)
18. AJ Sanyal 2002 AGA technical review on nonalcoholic fatty liver disease Gastroenterology 21 27 41
19. EM Brunt 2001 Nonalcoholic steatohepatitis: definition and pathology Semin Liver Dis 21 3 16 10.1055/s-2001-12925 1:STN:280:DC%2BD3MrgsVGrtg%3D%3D 11296695
20. JN Feder A Gnirke W Thomas, et al. 1996 A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat Genet 13 399 408 10.1038/ng0896-399 1:CAS:528:DyaK28XkslOnurg%3D 8696333 (Pubitemid 26256612)
21. L Kazemi-Shirazi C Datz T Maier-Dobersberger, et al. 1999 The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C Gastroenterology 116 127 134 10.1016/S0016-5085(99)70236-2 1:CAS:528:DyaK1MXlsl2guw%3D%3D 9869610 (Pubitemid 29013501)
22. PC Adams S Chakrabarti 1998 Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria Gastroenterology 114 319 323 10.1016/S0016-5085(98)70483-4 1:STN:280:DyaK1c7hsVagtQ%3D%3D 9453492 (Pubitemid 28093539)
23. H Hayashi T Takikawa N Nishimura, et al. 1994 Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron Am J Gastroenterol 89 986 988 1:STN:280:DyaK2c3ovVSiuw%3D%3D 8017395 (Pubitemid 24201831)
24. Y Sumida K Kanemasa K Fukumoto, et al. 2006 Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: a pilot study Hepatol Res 36 315 321 10.1016/j.hepres.2006.08.003 1:CAS:528: DC%2BD28Xht1ersLjM 16971174 (Pubitemid 44718428)
25. LA Videla V Fernández G Tapia, et al. 2003 Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells Biometals 16 103 111 10.1023/A:1020707811707 1:CAS:528:DC%2BD38XnvFOhs7o%3D 12572670 (Pubitemid 36140221)
26. K Houglum M Filip JL Witztum, et al. 1990 Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload J Clin Invest 86 1991 1998 10.1172/JCI114934 1:CAS:528:DyaK3MXlvF2ksA%3D%3D 2123889
27. MB Kadiiska MJ Burkitt QH Xiang, et al. 1995 Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation J Clin Invest 96 1653 1657 10.1172/JCI118205 1:CAS:528:DyaK2MXnvVGqu7s%3D 7657835
28. A Pietrangelo 1998 Iron, oxidative stress and liver fibrogenesis J Hepatol 28 suppl 1 8 13 10.1016/S0168-8278(98)80368-1 1:CAS:528: DyaK1cXmslKks7Y%3D 9575442 (Pubitemid 28168254)
29. ED Lustbader HW Hann BS Blumberg 1983 Serum ferritin as a predictor of host response to hepatitis B virus infection Science 220 423 425 10.1126/science.6301008 1:CAS:528:DyaL3sXhvFGrtb8%3D 6301008 (Pubitemid 13163437)
30. EC Jazwinska LM Cullen F Busfield, et al. 1996 Haemochromatosis and HLA-H Nat Genet 14 249 251 10.1038/ng1196-249 1:CAS:528:DyaK28XntVClsLs%3D 8896549
31. Douabin V, Deugnier Y, Jouanolle AM, et al. Polymorphisms in the haemochromatosis gene. International Symposium on iron in biology and medicine. Saint-Malo, France, 1997, p 267.
32. S Chitturi M Weltman GC Farrell, et al. 2002 HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity Hepatology 36 142 149 10.1053/jhep.2002.33892 1:CAS:528:DC%2BD38Xlslyru7k%3D 12085358 (Pubitemid 34700771)
33. MM Deguti AM Sipahi LC Gayotto, et al. 2003 Lack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis Braz J Med Biol Res 36 739 745 10.1590/S0100- 879X2003000600009 1:CAS:528:DC%2BD3sXmtFamsbg%3D 12792703
34. A Duseja R Das M Nanda, et al. 2005 Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations World J Gastroenterol 11 393 395 15637751 (Pubitemid 40125247)
35. N Yamauchi Y Itoh Y Tanaka, et al. 2004 Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis J Gastroenterol 39 654 660 10.1007/s00535-003-1361-y 1:CAS:528:DC%2BD2cXmt1Kktb8%3D 15293136 (Pubitemid 39149353)
36. T Sohda J Yanai H Soejima, et al. 1999 Frequencies in the Japanese population of HFE gene mutations Biochem Genet 37 63 68 10.1023/A:1018718101579 1:CAS:528:DyaK1MXktVersbk%3D 10429833 (Pubitemid 29291605)
37. RL Dobbins LS Szczepaniak J Myhill, et al. 2002 The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats Diabetes 51 1825 1833 10.2337/diabetes.51.6.1825 1:CAS:528:DC%2BD38XktlSktLs%3D 12031970 (Pubitemid 34564295)
38. P Dongiovanni L Valenti A Ludovica Fracanzani, et al. 2008 Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver Am J Pathol 172 738 747 10.2353/ajpath.2008.070097 1:CAS:528:DC%2BD1cXktVKhu7c%3D 18245813 (Pubitemid 351354546)
39. L Valenti AL Fracanzani P Dongiovanni, et al. 2007 Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study Am J Gastroenterol 102 1251 1258 10.1111/j.1572-0241.2007.01192.x 1:CAS:528:DC%2BD2sXotFaitr8%3D 17391316 (Pubitemid 46802029)
40. S Chitturi S Abeygunasekera GC Farrell, et al. 2002 NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 373 379 10.1053/jhep.2002.30692 1:CAS:528:DC%2BD38XhsVGrt74%3D 11826411 (Pubitemid 34106377)